<DOC>
	<DOCNO>NCT00511732</DOCNO>
	<brief_summary>Designed evaluate dose response force-titrated prandial administration TI compare placebo ( TP ) subject Type 2 diabetes suboptimally control</brief_summary>
	<brief_title>18-Week , Randomized , Double-blind , Placebo Controlled , Forced Titration Study Patients With Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>Male female patient 18 &lt; 80 year age Clinical diagnosis type 2 diabetes mellitus Duration diabetes &gt; 3 year &lt; 20 year Glycemic control upper end acceptable level suboptimal control ( HbA1c 7.0 % 12 ? 0 % ) Confirmation diagnosis diabetes history 2 hour postprandial blood glucose &gt; 11.1 mmol/L ( 200 mg/dL ) follow glucose tolerance test A minimum 2 month treatment stable dose one follow antihyperglycemic agent : sulphonylureas , alpha glucosidase inhibitor , metformin , meglitinides , thiazolidinediones and/or Lantus basal insulin therapy FBG : &gt; 6 mmol/L ( 108 mg/dL ) Cpeptide : &gt; 0.5 nmol/L BMI &lt; 38 kg/m2 Baseline DLco , FVC , FEV1 &gt; 75 % predict normal Subjects , opinion Investigator , able complete study Written inform consent Severe complication diabetes include history : blindness grade III IV diabetic retinopathy , renal failure require dialysis transplantation , amputation limb digit relate diabetic vasculopathy foot ulcer Treatment another investigational drug within 3 month prior study entry duration study History drug alcohol dependency Significant hepatic disease ( evidenced ALT AST &gt; 3 time normal upper reference range bilirubin &gt; 1.5 time normal upper reference range ) Significant renal disease ( evidenced creatinine &gt; 1.5 mg/dL male &gt; 1.3 mg/dL female ) proteinuria &gt; 1,000 mg/24 hour History chronic obstructive pulmonary disease , history know chronic pulmonary disease , reactive airway disease , chronic bronchitis , emphysema , asthma Heart disease grade class III class IV accord New York Heart Association criteria Prior treatment , participation clinical study involve inhaled insulin product Smokers Current use preprandial prandially administer fastacting rapid act insulin insulin analogs Previous participation TI TP clinical trial Allergy insulin drug use part clinical trial History malignancy within 5 year study entry ( basal cell carcinoma ) Anemia ( hemoglobin level less 11 g/dL female 12 g/dL male study entry ) Diagnosis Acquired Immunodeficiency Syndrome ( AIDS ) Aids Related Complex A major psychiatric disorder preclude satisfactory participation study Subjects myocardial infarction stroke within precede 6 month Prior diagnosis systemic autoimmune collagen vascular disease require previous current treatment systemic corticosteroid , cytotoxic drug , penicillamine History severe multiple allergy Progressive fatal disease Recent loss ( within past 2 month ) &gt; 5 % body weight Evidence `` moderate '' great ketone urine history ketoacidosis Use medication know modify glucose metabolism ability recover hypoglycemia oral , parenteral inhaled steroid , great 25 mg hydrochlorothiazide daily Women pregnant lactate Women childbearing potential practicing inadequate birth control ( adequate birth control define use oral contraceptive , condom diaphragms spermicide , intrauterine device , surgical sterilization ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 2012</verification_date>
</DOC>